EP2874651
COMPOUNDS FOR TARGETED IMMUNOTHERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.7.2013EP published:
24.5.2023EP application number:
13820359.1
EPO information:
European Patent Register
Max expiry date:
15.7.2033
Title in English:
COMPOUNDS FOR TARGETED IMMUNOTHERAPYLanguage of the patent:
English
Timeline
Today
16.7.2013EP application
24.5.2023EP Publication
Owner
Name:
Birdie Biopharmaceuticals Inc.Address:
Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman, KY
Inventor
Name:
LI, LixinAddress:
Beijing 100600, CN
Priority
Number:
201210248481Date:
18.7.2012Country:
CN
Classification
Categories:
A61K 47/68, A61K 39/39, A61P 35/00, A61P 35/02, A61P 35/04